MARKET

EDSA

EDSA

Edesa Biotech Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.090
-0.090
-4.13%
Closed 16:00 04/02 EDT
OPEN
2.070
PREV CLOSE
2.180
HIGH
2.090
LOW
2.070
VOLUME
460
TURNOVER
--
52 WEEK HIGH
15.60
52 WEEK LOW
1.580
MARKET CAP
18.52M
P/E (TTM)
-2.4170
1D
5D
1M
3M
1Y
5Y

EPS

EDSA News

More
  • EDSA: Initiating Coverage of Edesa Biotech, Inc.; Dermatology and GI Focused Drug Development
  • Zacks Small Cap Research · 19h ago
  • Edesa Biotech to Develop Novel Treatment for Vitiligo in Collaboration with the National Research Council of Canada
  • ACCESSWIRE · 03/12 12:30
  • The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index
  • Benzinga · 03/10 13:19
  • The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
  • Benzinga · 02/28 12:28

Industry

Biotechnology & Medical Research
+3.33%
Pharmaceuticals & Medical Research
+2.80%

Hot Stocks

Symbol
Price
%Change

About EDSA

Edesa Biotech Inc., Stellar Biotechnologies, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the development of therapeutics for dermatological and gastrointestinal indications. The Company’s lead product candidate, EB01, is a novel non-steroidal anti-inflammatory molecule (sPLA2 inhibitor) for the treatment of chronic allergic contact dermatitis. The Company has its operations in the United States and in Canada.
More

Webull offers kinds of Edesa Biotech Inc stock information, including NASDAQ:EDSA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EDSA stock news, and many more online research tools to help you make informed decisions.